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SHORT REPORT
A Direct Approach for the Correction of Persistent Endoleak:
a Technical Report
R. J. Banks, H. Ashour, A. Mudawi and R. Uberoi∗
Queen Elizabeth Hospital, Sherriff Hill, Gateshead, Tyne and Wear NE9 6SX, U.K.
Endovascular repair of infrarenal abdominal aortic aneurysms is becoming more widespread, with the use of a variety of
different devices. They all share a subsequent risk of endoleak, which averages 25%. Type I leaks and type II leaks with
increasing sac size should ideally be treated endovascularly. Embolisation through collaterals into the sac is not always
achievable. We describe a case of a type II endoleak where a direct puncture of the endoleak cavity was carried out under
fluoroscopy, with subsequent embolisation using Spongistan and thrombin glue to occlude the leak.
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Introduction as well as the endoleak cavity in the sac to achieve
occlusion and prevent further sac expansion. This is
Endovascular repair of abdominal aortic aneurysms is not always feasible and we describe a case where
attempted embolisation though collateral pathwaysbecoming more widespread with the use of a variety
of different devices. They share an endoleak rate of failed and a direct sac puncture and embolisation of
the endoleak cavity was carried out.between 6%1 and 52%2 with an average across both
immediate and delayed leaks of 24% reported.3
Endoleaks have been classified and subdivided in a
number of articles by White et al.4,5 to describe them
Materials and Methodsas: Type I: due to inadequate seal at the attachment
sites. Type II: lumbar or inferior mesenteric backflow. A 75-year-old lady with angina and severe chronicType III: due to damage/derangement of the stent obstructive airways disease (COAD) was treated en-graft. Type IV: those associated with graft wall porosity. dovascularly for a 5.2 cm infra-renal aortic aneurysmThere is a further distinction made as to whether using the Zenith bifurcated stent graft (Cook, U.K.).there is inflow but no outflow (subgroup A) or inflow The operative procedure was carried out uneventfullyand outflow (subgroup B) when considering type I with no evidence of endoleak at the end of the pro-and type II leaks. cedure. A duplex scan on the first postoperative dayThere is general agreement that direct perfusion revealed a small endoleak coming from the inferiorof the sac (type I leaks) should be treated, but the mesenteric artery. A dual phase CT scan 3 days latermanagement of type II endoleaks is less clear although showed this to have spontaneously sealed with nothe presence of an expanding sac is a worrying sign evidence of a leak and good flow noted within the graft,and often necessitates treatment. Endovascular man- confirmed subsequently with repeat duplex beforeagement is desirable wherever possible, particularly discharge. At three months stent surveillance, duplexin the presence of severe medical risk factors. Collateral and dual phase CT demonstrated a type II endoleakpathways can be used to embolise the feeding vessels6 filling a small cavity via lumbar vessels (Fig. 1). The
size of the endoleak cavity increased at 12 months and
∗ Please address all correspondence to: R. Uberoi, Consultant Ra- the leak became more obvious (Fig. 2). The sac diameterdiologist, Queen Elizabeth Hospital, Sherriff Hill, Gateshead, Tyne
and Wear NE9 6SX, U.K. however remained unchanged. At 18 months, both the
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Fig. 1. Axial CT with 150 ml IV contrast at 3 months showing a small endoleak (arrow) in the posterior part of the sac.
Fig. 2. Axial CT with 150 ml IV contrast at 12 months showing an enlarged endoleak cavity (black arrow) with visible lumbar feeding
vessel (white arrow).
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Fig. 3. Axial CT with 150 ml IV contrast at 18 months showing a considerably enlarged endoleak cavity.
Fig. 4. 18 G mandrel wire inserted into the sac via a 22 G chuba needle.
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Fig. 5. Arrow shows residual contrast in the surrounding sac and occlusion of the proximal right lumbar vessel
Fig. 6. CT with IV contrast following procedure showing occlusion of the endoleak and a bubble of gas presumed to have been introduced
during the embolisation procedure.
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size of the endoleak cavity and the aneurysm sac had 7.6% of cases and make up almost half of the total of
16.8% of patients who have endoleaks identified onincreased (from 45 mm to 49 mm in the AP and 45 mm
to 50 mm in transverse dimension) on CT scan (Fig. completion angiography. Follow-up of all stented
patients shows a reduction in the total number of3).
The decision was taken at this stage to treat the endoleaks to 11.4% at 1 month post op, of which 4.9%
are type II. These figures remain essentially constantendoleak. An initial attempt to coil the lumbar arteries
via tortuous collaterals from the internal iliac was up to 2 years post op, although late onset endoleaks
have also been reported.9unsuccessful. It was therefore decided to carry out a
direct sac puncture and embolisation under fluoro- In our case there was an initial phase of resolution
of the sac following the placement of the stent graftscopic screening.
The patient was given a single dose of 1.5 g of despite the endoleak and it was decided that no inter-
vention was warranted. However when persistentcefuroxime intravenously immediately prior to the
procedure. An angiogram to opacify the endoleak back flow with enlargement of the endoleak cavity
and aneurysm sac was observed, indicating that thecavity was carried out. The patient was then placed
in a semi-prone position and the site of the sac marked aneurysmal sac was still under pressure. It was felt
that active treatment of the endoleak was warranted,using both angiographic views and the CT scans.
The sac was punctured using a 22 G chiba needle given that perigraft endoleaks with sac expansion are
accepted as dangerous and subsequent rupture wellunder fluoroscopic guidance using a C arm (Philips
Multidiagnost 3), the endoleak cavity was opacified recorded.10 Growth of the sac in cases such as this has
been attributed to the lumbar vessels in the past,9and a 0.18 G Mandril wire introduced into the sac (Fig.
4). The track was dilated with a 5 Fr dilator (Cordis, which do not generally lead to sac dilatation.11
The method and timing, as well as the exact modalityU.K.), which was also used for the embolisation pro-
cedure. A removable haemostatic valve (Baird, U.K.) of treatment in cases of delayed type II endoleaks is
much less clear than in the case of type I attachmentwas placed on the end of the dilator to allow flushing.
Spongostan (Johnson & Johnson) was cut into small leaks where immediate intervention, either surgical or
endovascular is usually indicated. Embolisation ofrectangles and injected into the sac together with a
small amount of contrast (Omnipaque 300). When flow these feeding vessels in type II endoleaks has been
described where access to the sac has been gained viain the sac had decreased, thrombin glue (Tisseel Fibrin
Sealant, Baxter Healthcare) was used to complete the the internal iliac vessels.6 In this case, this was not
technically possible due to the anatomy, and we haveocclusion of the sac. The subsequent angiogram and
CT showed complete seal with no evidence of further presented a relatively simple technique where the
successful occlusion of the sac was carried out usingendoleak (Fig. 6). CT at 6 months showed again no
evidence of endoleak. a direct approach. The size of the endoleak cavity in
this case made a direct endovascular approach both
feasible and relatively safe, but this may not be ap-
propriate where the endoleak cavity is smaller. It is
Discussion also very important to maintain aseptic technique
thoughout with antibiotic cover as introduction of
Parodi7 is credited with the development of the stent infection could be disastrous in the presence of the
graft treatment of abdominal aortic aneurysm, de- stent graft. We chose to use a combination of spon-
scribed in 1991. Since then we have seen a significant giostan and thrombin for embolisation, as these are
increase in the number of endovascular repairs of relatively easy to inject and will eventually resorb
abdominal aortic aneurysms as a minimally invasive allowing the aneurysm sac to continue to shrink.
alternative to the ‘‘standard’’ surgical repair, with the With the number of endovascular stent graft pro-
proportion of aneurysms being treated with this tech- cedures set to rise, and with them, the number of such
nique set to rise still further. Whilst the incidence of complications, we feel this is a valuable technique
complications compares favourably with that of open that warrants further evaluation as a second line of
repair, endovascular leak forms a significant pro- intervention when indirect methods have failed.
portion of complications in stent graft repair, typically
quoted as 25%3 ranging from 6%1 to 52%.2
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